Clinical experience of FK 506 for renal allograft transplantation.
Kitamura
M
M
Department of Transplantation I, Tokai University School of Medicine, Kanagawa, Japan.
Hiraga
S
S
Kobayashi
D
D
Kakuta
T
T
Fukuuchi
F
F
Hida
M
M
Satoh
T
T
D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D012263:Ribonucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone